files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346
121
Views
8
Downloads

Assessment of Clinical Profile, Treatment Outcome of Individuals Treated for Delusional Disorder

Manish Bhargava
Page: 188-191 | Received 10 Sep 2013, Published online: 30 Sep 2013

Full Text Reference XML File PDF File

Abstract

Due to the nature of delusions, many patients deny the disease and refuse treatment. A positive response to treatment is observed in a high proportion of patients,1 and many patients can maintain overtly normal activities. Given the long history of PDD as a psychiatric diagnosis, very few studies have specifically researched this condition, with most of the available information being retrospective. Duration of illness was defined as the time between the onset of illness and the age at first consultation in our OPD. The total duration of contact was the total duration for which the patient was followed up. Treatment response was assessed for patients who received anti‐psychotics = 300mg chlorpromazine equivalents for at least 12 weeks. Initial assessment of the patient in the OPD was done by the postgraduate resident after conducting a formal mental status examination which was then verified by the consultant psychiatrist. On further follow up the patients were assessed by the consultant psychiatrist. 30 (29.4%) had positive family history while 38 (55.8%) had no family history of any related illness. Among patients the common delusions were infidelity and persecution with a frequency of 44 (64.7%) and 19 (27.9%) respectively. The delusional disorder has much co‐morbidity. Non‐compliance with the treatment must be addressed meticulously. But the level of functioning is found to be reasonably fair irrespective of the treatment status. Though the information gathering was through telephone call it was found to be working well.


How to cite this article:

Manish Bhargava. Assessment of Clinical Profile, Treatment Outcome of Individuals Treated for Delusional Disorder.
DOI: https://doi.org/10.36478/10.59218/makrjms.2013.188.191
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2013.188.191